| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |